1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

14 Sep 2024
Admin
News Article

C-CAMP Partners with UK’s GAMRIF to Tackle Antimicrobial Resistance

C-CAMP partners with UK’s GAMRIF which chips Rs. 56 crore to tackle AMR, invites Indian innovators

Overview

UK’s Global AMR Innovation Fund (GAMRIF) and Centre for Cellular and Molecular Platforms (C-CAMP) in India have partnered to foster the identification and development of world-class antimicrobial resistance (AMR) -focused innovative solutions to address environmental factors of AMR.

Focus on Developing Countries

The project has a special focus on addressing challenges in low- and middle-income countries (LMICs) with local, contextual solutions. Through GAMRIF’s funding commitment of up to £5.1 million, or Rs. 56 crore over 3 years, the programme aims to support up to 15 innovative solutions.

About the Programmes

In the inaugural call for innovations, the programme has prioritised problems across different realms of detection, prevention, and treatment of the causal factors of AMR in the environment.
The programme will focus on mid- to late-stage development to accelerate promising innovative solutions, with a few to be supported for on-field validation and testing.
This is intended to scale-up these innovative solutions such that the gaps can be plugged in India, and also in LMICs, to curtail the spread of AMR in the environment, driving surveillance, monitoring, and guiding appropriate practices and policy.
Last month, an inter-sectoral stakeholders’ meeting was convened under this programme to identify areas in the environment - AMR nexus that can be addressed by innovative solutions.
These deliberations, and many others, have formed the basis of the identification of the prioritised problems in the inaugural call, that include, Innovative solutions to detect resistant microbes, resistant markers or antimicrobial traces in the environment.

Innovative Solutions

Innovative solutions to prevent the spread of potential causal factors of antimicrobial resistance in the environment.
This could be solutions to prevent the leaching of antibiotics into the environment, our water sources, our food and crops, and proposing solutions for effluent neutralisation and bioremediation.
Innovative solutions for neutralising or reducing the potential causal factors of AMR in the environment.

Words from CEO: C-CAMP

Dr. Taslimarif Saiyed, director-CEO, C-CAMP has said, the partnership with GAMRIF provides us a never-before opportunity to nurture startups across the whole value chain of solutions from idea identification to productisation, deployment and integration of innovation.
“Though this C-CAMP GAMRIF AMR Challenge in the environment, we are looking to push market-ready technologies in their last sprint to product and product to market”, he said.

British Acting High Commissioner to India has been an enabler and catalyser of this landmark GAMRIF-C-CAMP partnership.

From British Deputy High Commissioner (India)

Christina Scott, British Deputy High Commissioner to India, said: “UK’s Global AMR Innovation Fund and C-CAMP have announced their first call for Indian innovators to tackle this silent pandemic. It is wonderful that this initiative is offering £5 million funding over the next three years to support up to 15 innovative solutions in India. This is an important step towards curbing AMR’s impact in India.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!